ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

White House Defers to Pressure, Gives Up Attempt to Cut NIH Budget $334 Million In ‘87

March 6, 1987

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

Funding Opportunities.

May 24, 2002

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997